At the population level, the patient groups with the highest cost and quality-adjusted life year impacts were 65–100-year-old females, followed by males, with uncomplicated UTIs. At an individual ...
The FDA has approved Allecra Therapeutics' Exblifep, a combination antibiotic for complicated urinary tract infections (cUTIs) that will now launch later this year, but turned down a rival product ...
The diagnosis of symptomatic UTI among older adults is complicated by the high prevalence of asymptomatic bacteriuria, which does not require any treatment, and the difficulty in interpreting the ...
Are you tired of the constant sting and discomfort caused by urinary tract infections or UTIs? If yes, you are not alone. Every year, millions of people, mostly women, encounter this uncomfortable ...
US and MCUG for all children aged <2 years. 99m Tc–DMSA scan in high-grade reflux [3] Urinary tract infection (UTI) is the most common serious bacterial infection in childhood, and its ...
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on ...
UTI Asset Management Company Ltd., incorporated in the year 2002, is a Small Cap company (having a market cap of Rs 16,574.53 Crore) operating in Financial Services sector. UTI Asset Management ...
1. Current NAV: The Current Net Asset Value of the UTI Flexi Cap Fund - Regular Plan as of Nov 27, 2024 is Rs 320.72 for Growth option of its Regular plan. 2. Returns: Its trailing returns over ...
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced the publication of a paper by Sapko, et. al. in the ...